Agree that for a potential partner, financially this wouldn't make sense, but maybe if Cytodyn requested it or partner is prohibited from buying on open market due to ongoing discussions?

Other possibilities could include having backstop ability to raise funds at higher prices to fund future trials unrelated to a partner.